Dr. Vogelzang, MD, FASCO, FACP

MESOTHELIOMA SPECIALIST

Dr. Nicholas Vogelzang, MD, FASCO, FACP has dedicated his professional life to researching and treating rare forms of cancer. He revolutionized mesothelioma treatment in discovering the first life-extending treatment for the disease. This drug combination therapy of ALIMTA and CISPLATIN continues to be the standard of care today.

YOU WILL HAVE ACCESS TO A WORLD-RENOWNED ONCOLOGIST IN THE FIELD OF MESOTHELIOMA

Dr. Vogelzang, MD, FASCO, FACP has published over 100 articles on mesothelioma and is the co-author and co-editor of Malignant Mesothelioma, Advances in Pathogenesis, Diagnosis, and Translational Therapies. With hundreds of speaking engagements worldwide, he continues advancing initiatives to eradicate mesothelioma.

See a list of Dr. Vogelzang’s publications here.


 

Top doctors annual issue names dr. vogelzang a top oncologist